Russell Investments Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-120
| Closed | -$5.08K | – | 3648 |
|
|
2024
Q1 | $5.08K | Buy |
+120
| New | +$5.08K | ﹤0.01% | 2940 |
|
|
2022
Q4 | – | Sell |
-318
| Closed | -$9K | – | 2985 |
|
|
2022
Q3 | $9K | Hold |
318
| – | – | ﹤0.01% | 2868 |
|
|
2022
Q2 | $11K | Sell |
318
-779
| -71% | -$26.9K | ﹤0.01% | 2842 |
|
|
2022
Q1 | $47K | Sell |
1,097
-185
| -14% | -$7.93K | ﹤0.01% | 2631 |
|
|
2021
Q4 | $64K | Hold |
1,282
| – | – | ﹤0.01% | 2881 |
|
|
2021
Q3 | $82K | Hold |
1,282
| – | – | ﹤0.01% | 2908 |
|
|
2021
Q2 | $92K | Hold |
1,282
| – | – | ﹤0.01% | 3067 |
|
|
2021
Q1 | $95K | Sell |
1,282
-2,585
| -67% | -$192K | ﹤0.01% | 2982 |
|
|
2020
Q4 | $279K | Hold |
3,867
| – | – | ﹤0.01% | 2653 |
|
|
2020
Q3 | $210K | Hold |
3,867
| – | – | ﹤0.01% | 2762 |
|
|
2020
Q2 | $257K | Hold |
3,867
| – | – | ﹤0.01% | 2627 |
|
|
2020
Q1 | $241K | Buy |
3,867
+434
| +13% | +$27K | ﹤0.01% | 2482 |
|
|
2019
Q4 | $303K | Sell |
3,433
-82
| -2% | -$7.24K | ﹤0.01% | 2575 |
|
|
2019
Q3 | $268K | Sell |
3,515
-44
| -1% | -$3.36K | ﹤0.01% | 2503 |
|
|
2019
Q2 | $304K | Sell |
3,559
-183
| -5% | -$15.6K | ﹤0.01% | 2415 |
|
|
2019
Q1 | $400K | Buy |
3,742
+2,135
| +133% | +$228K | ﹤0.01% | 2414 |
|
|
2018
Q4 | $136K | Sell |
1,607
-23,130
| -94% | -$1.96M | ﹤0.01% | 2679 |
|
|
2018
Q3 | $2.43M | Buy |
24,737
+871
| +4% | +$85.6K | ﹤0.01% | 1663 |
|
|
2018
Q2 | $2.76M | Sell |
23,866
-833
| -3% | -$96.3K | 0.01% | 1600 |
|
|
2018
Q1 | $2.44M | Sell |
24,699
-8,140
| -25% | -$803K | ﹤0.01% | 1721 |
|
|
2017
Q4 | $3.44M | Buy |
32,839
+30,582
| +1,355% | +$3.2M | 0.01% | 1537 |
|
|
2017
Q3 | $254K | Hold |
2,257
| – | – | ﹤0.01% | 2623 |
|
|
2017
Q2 | $253K | Buy |
2,257
+156
| +7% | +$17.5K | ﹤0.01% | 2636 |
|
|
2017
Q1 | $245K | Hold |
2,101
| – | – | ﹤0.01% | 2650 |
|
|
2016
Q4 | $220K | Buy |
+2,101
| New | +$220K | ﹤0.01% | 2699 |
|